BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 112 filers reported holding BIOSCRIP INC in Q2 2016. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $307,000 | -76.0% | 153,671 | -57.2% | 0.26% | -77.9% |
| Q4 2018 | $1,280,000 | -0.3% | 358,742 | -13.4% | 1.17% | +17.2% |
| Q3 2018 | $1,284,000 | +34.5% | 414,391 | +27.1% | 1.00% | +37.3% |
| Q2 2018 | $955,000 | -54.9% | 326,156 | -62.1% | 0.73% | -28.9% |
| Q1 2018 | $2,116,000 | +29.2% | 860,498 | +51.8% | 1.02% | -48.2% |
| Q3 2016 | $1,638,000 | +18.1% | 566,812 | +4.2% | 1.98% | -12.4% |
| Q2 2016 | $1,387,000 | -1.0% | 543,862 | -16.9% | 2.26% | +17.2% |
| Q1 2016 | $1,401,000 | – | 654,648 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |